CaaS Capital Management
North America, New York, United States, New York
Description
CaaS Capital Management is investing across all regions, industries, and capital structures.
Investor Profile
CaaS Capital Management has backed more than 15 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 7% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States, Germany, United Kingdom.
- Strong thematic focus on Biotechnology, Biopharma, Therapeutics.
Stage Focus
- Series C (33%)
- Series B (33%)
- Post Ipo Equity (20%)
- Private Equity (7%)
- Series D (7%)
Country Focus
- United States (87%)
- Germany (7%)
- United Kingdom (7%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Biopharma
- Therapeutics
- Health Care
- Life Science
- Pharmaceutical
- Genetics
- Oncology
- Medical
- Information Technology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
